title: CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells.
abstract: Myocardial infarction triggers an inflammatory reaction that is involved in cardiac remodeling. Cardiac repair is dependent on regulatory mechanisms that suppress inflammation and prevent excessive matrix degradation. Chemokine induction in the infarcted heart mediates recruitment of leukocyte subsets with distinct properties. We demonstrate that signaling through the CC chemokine receptor 5 (CCR5) prevents uncontrolled postinfarction inflammation and protects from adverse remodeling by recruiting suppressive mononuclear cells. CCR5 and its ligands macrophage inflammatory protein (MIP)-1alpha and MIP-1beta were markedly induced in the infarcted mouse myocardium. In addition, almost 40% of the mononuclear cells infiltrating the infarct expressed CCR5. CCR5(-/-) mice exhibited marked upregulation of proinflammatory cytokine and chemokine expression in the infarct. In wild-type infarcts CCR5+ mononuclear cells had anti-inflammatory properties, expressing higher levels of IL-10 than CCR5- cells. In contrast, mononuclear cells isolated from CCR5(-/-) infarcts had reduced IL-10 expression. Moreover, enhanced inflammation in the absence of CCR5 was associated with impaired recruitment of CD4+/foxp3+ regulatory T cells (Tregs). The CCR5+ Treg subset exhibited increased IL-10 expression, reflecting potent anti-inflammatory activity. Accentuated inflammation in CCR5(-/-) infarcts was associated with increased matrix metalloproteinase (MMP) expression, reduced TIMP levels, and enhanced MMP-2 and MMP-9 activity, resulting in worse cardiac dilation. These results suggest that CCR5-mediated Treg recruitment may restrain postinfarction inflammation, preventing excessive matrix degradation and attenuating adverse remodeling.
authors.affiliation: Section of Cardiovascular Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: Marcin
authors.initials: M
authors.lastname: Dobaczewski
authors.forename: Ying
authors.initials: Y
authors.lastname: Xia
authors.forename: Marcin
authors.initials: M
authors.lastname: Bujak
authors.forename: Carlos
authors.initials: C
authors.lastname: Gonzalez-Quesada
authors.forename: Nikolaos G
authors.initials: NG
authors.lastname: Frangogiannis
mesh_terms: D000818:Animals; D054405:Chemokine CCL3 / Q000378:metabolism; D054407:Chemokine CCL4 / Q000378:metabolism; D004452:Echocardiography / Q000379:methods; D005260:Female; D007249:Inflammation; D016753:Interleukin-10 / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000378:metabolism; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009203:Myocardial Infarction / Q000378:metabolism / Q000473:pathology*; D019713:Receptors, CCR5 / Q000378:metabolism*; D013601:T-Lymphocytes / Q000378:metabolism*; D050378:T-Lymphocytes, Regulatory / Q000378:metabolism
chemical_list: D054405:Chemokine CCL3; D054407:Chemokine CCL4; D019713:Receptors, CCR5; D016753:Interleukin-10; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9
references.citation: J Immunol. 1999 Nov 1;163(9):4642-6
references.pmid: 10528159
references.citation: J Exp Med. 2007 Nov 26;204(12):3037-47
references.pmid: 18025128
references.citation: Nat Immunol. 2007 May;8(5):457-62
references.pmid: 17440451
references.citation: Virology. 2001 Sep 15;288(1):8-17
references.pmid: 11543653
references.citation: Immunity. 2009 May;30(5):616-25
references.pmid: 19464984
references.citation: Cell. 1997 Oct 31;91(3):385-95
references.pmid: 9363947
references.citation: Nat Immunol. 2008 Sep;9(9):970-80
references.pmid: 18711434
references.citation: Nat Immunol. 2005 Apr;6(4):338-44
references.pmid: 15785759
references.citation: Physiol Rev. 2007 Oct;87(4):1285-342
references.pmid: 17928585
references.citation: J Exp Med. 2006 Oct 30;203(11):2451-60
references.pmid: 17015634
references.citation: J Cell Mol Med. 2008 Apr;12(2):496-506
references.pmid: 18088392
references.citation: J Exp Med. 1999 Oct 4;190(7):995-1004
references.pmid: 10510089
references.citation: Gastroenterology. 2007 Mar;132(3):966-81
references.pmid: 17324406
references.citation: Immunity. 2008 Apr;28(4):546-58
references.pmid: 18387831
references.citation: Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):1907-39
references.pmid: 17034340
references.citation: J Clin Invest. 1993 Nov;92(5):2303-12
references.pmid: 8227345
references.citation: Pharmacol Res. 2008 Aug;58(2):88-111
references.pmid: 18620057
references.citation: Cardiovasc Res. 2006 Feb 15;69(3):604-13
references.pmid: 16360129
references.citation: Am J Pathol. 2008 Jul;173(1):57-67
references.pmid: 18535174
references.citation: Am J Pathol. 2000 Jun;156(6):1951-9
references.pmid: 10854218
references.citation: J Immunol. 1998 Apr 15;160(8):4018-25
references.pmid: 9558111
references.citation: Immunity. 2003 Jul;19(1):71-82
references.pmid: 12871640
references.citation: Circulation. 2007 Nov 6;116(19):2127-38
references.pmid: 17967775
references.citation: J Immunol. 2008 Mar 1;180(5):3049-56
references.pmid: 18292527
references.citation: J Am Coll Cardiol. 2008 Apr 8;51(14):1384-92
references.pmid: 18387441
references.citation: J Immunol. 2008 Nov 1;181(9):6546-56
references.pmid: 18941245
references.citation: J Immunol. 2009 Feb 1;182(3):1746-55
references.pmid: 19155524
references.citation: Circulation. 2003 Nov 11;108(19):2387-92
references.pmid: 14568904
references.citation: J Clin Invest. 2007 Sep;117(9):2692-701
references.pmid: 17694177
references.citation: J Interferon Cytokine Res. 2002 Feb;22(2):223-9
references.pmid: 11911805
references.citation: Circulation. 2005 Jun 7;111(22):2935-42
references.pmid: 15927970
references.citation: Thromb Haemost. 2007 May;97(5):738-47
references.pmid: 17479184
references.citation: Nat Med. 1999 Oct;5(10):1135-42
references.pmid: 10502816
references.citation: J Virol. 2007 Sep;81(18):10101-12
references.pmid: 17626099
references.citation: Am J Pathol. 2004 Feb;164(2):665-77
references.pmid: 14742270
references.citation: Circ Res. 2000 Jun 23;86(12):1259-65
references.pmid: 10864917
references.citation: Circ Res. 2005 Apr 29;96(8):881-9
references.pmid: 15774854
references.citation: J Clin Invest. 2007 Jan;117(1):185-94
references.pmid: 17200718
references.citation: Am J Pathol. 2004 Aug;165(2):439-47
references.pmid: 15277218